ADHERENCE AND PERSISTENCE OF ORAL ANTICOAGULANTS FOR TREATMENT OF ATRIAL FIBRILLATION ACROSS STROKE AND BLEEDING RISK STRATA

被引:0
|
作者
Ko, G. [1 ]
Brouwer, E. [2 ]
Dayer, V [3 ]
Katta, A. [4 ]
Ramsey, S. [2 ]
Lopes, M. [5 ]
Singh, R. [1 ]
Kong, S. X. [1 ]
机构
[1] Bayer US LLC, Whippany, NJ USA
[2] Curta Inc, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Bayer Healthcare Pharmaceut Inc, Jersey City, NJ USA
[5] MMDLOPES LLC, Cresskill, NJ USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR233
引用
收藏
页码:S339 / S339
页数:1
相关论文
共 50 条
  • [1] Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Alexander, G. Caleb
    Crown, William
    Montori, Victor M.
    Sangaralingham, Lindsey R.
    Gersh, Bernard J.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02): : 1 - 12
  • [2] Determinants of adherence to oral anticoagulants in patients with atrial fibrillation and stroke
    Polymeris, A.
    Traenka, C.
    Hert, L.
    Seiffge, D. J.
    Peters, N.
    de Marchis, G. M.
    Bonati, L.
    Lyrer, P. A.
    Engelter, S. T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 363 - 363
  • [3] A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
    Kehinde O. Obamiro
    Leanne Chalmers
    Luke R. E. Bereznicki
    [J]. American Journal of Cardiovascular Drugs, 2016, 16 : 349 - 363
  • [4] A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
    Obamiro, Kehinde O.
    Chalmers, Leanne
    Bereznicki, Luke R. E.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (05) : 349 - 363
  • [5] Oral anticoagulants in patients with atrial fibrillation having an intermediate risk of ischemic stroke but a high risk of bleeding
    Chao, T. F.
    Chen, S. A.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2977 - 2977
  • [6] Assessing methods to ascertain persistence and adherence of oral anticoagulants in patients with atrial fibrillation
    Tan, Anran
    Sreedhara, Sushama Kattinakere
    Russo, Massimiliano
    Singer, Daniel E.
    Lauffenburger, Julie C.
    Dicesare, Elyse
    Lin, Kueiyu Joshua
    [J]. AMERICAN HEART JOURNAL, 2024, 278 : 161 - 169
  • [7] Balancing Efficacy and Bleeding Risk in the Prevention of Stroke Due to Atrial Fibrillation with Newer Oral Anticoagulants
    Agarwal, M. B.
    Verma, Subhash
    Mahapatra, Manoranjan
    Tripathi, A. K.
    Bhave, Abhay
    Deshpande, Anand
    Vora, Amit
    Dalal, Jamshed J.
    Shah, A. B.
    Bichu, S.
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (03) : 129 - 143
  • [8] Balancing Efficacy and Bleeding Risk in the Prevention of Stroke Due to Atrial Fibrillation with Newer Oral Anticoagulants
    M. B. Agarwal
    Subhash Verma
    Manoranjan Mahapatra
    A. K. Tripathi
    Abhay Bhave
    Anand Deshpande
    Amit Vora
    Jamshed J. Dalal
    A. B. Shah
    S. Bichu
    [J]. Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 129 - 143
  • [9] Risk of gastrointestinal bleeding in Asian patients receiving oral anticoagulants for stroke prevention in atrial fibrillation
    Diaz, Alejandro Bimbo
    Chow, Jeremy
    Hoo, Fan Kee
    Keong, Gary Lee Chin
    Venketasubramanian, Narayanaswamy
    Rey, Nannette
    Rogelio, Gregorio
    Mehta, Radhika
    [J]. DRUGS IN CONTEXT, 2024, 13
  • [10] Long-term adherence and persistence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
    Komen, Joris
    Heerdink, Rob
    Klungel, Olaf
    Mantel-Teeuwisse, Aukje
    Forslund, Tomas
    Wettermark, Bjorn
    Hjemdahl, Paul
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 648 - 649